The drug companies are not simply ‘ crying wolf’ when they say their success in high technology will be jeopardised if the Greenfield recommendation for generic substitution are enforced.
The drug companies are not simply ‘ raising a false alarm when they say their success in high technology will be jeopardised if the Greenfield recommendation for generic substitution are enforced.